## Diagnostic Approach to Nephrotic Syndrome **Key Point:** Renal biopsy is the gold standard for establishing the histological diagnosis of nephrotic glomerulonephritis when clinical and serological findings do not clearly point to a specific etiology. ### Why Renal Biopsy Is Indicated Here This patient presents with: - Nephrotic-range proteinuria (>3.5 g/day) - Hypoalbuminemia and clinical edema - **Normal complement levels** (excludes post-infectious GN, lupus nephritis, membranoproliferative GN) - **Negative ANA** (excludes SLE) - Normal renal size and echogenicity (excludes chronic kidney disease) These findings suggest a primary glomerulonephritis (likely Minimal Change Disease, Focal Segmental Glomerulosclerosis, or Membranous Nephropathy), but **only renal biopsy can differentiate** between these entities. ### Biopsy Technique & Findings | Histology | Light Microscopy | Immunofluorescence | Electron Microscopy | |-----------|------------------|-------------------|---------------------| | **Minimal Change** | Normal glomeruli | Negative | Foot process effacement | | **FSGS** | Segmental sclerosis | IgM, C3 in sclerotic areas | Foot process effacement + sclerosis | | **Membranous** | Thickened GBM | IgG, C3 (granular) | Subepithelial deposits ("spikes") | **Clinical Pearl:** The combination of normal complement, negative ANA, and nephrotic presentation makes primary glomerulonephritis most likely, and biopsy is essential for treatment planning (steroids for MCD/FSGS vs. immunosuppression for membranous). **High-Yield:** Renal biopsy is **diagnostic gold standard** when serological markers do not explain nephrotic syndrome. It guides treatment intensity and predicts prognosis. [cite:Robbins 10e Ch 20]
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.